The Mesothelioma Center News – Page 15
-
news
Research & Clinical TrialsResearch for a new type of mesothelioma treatment is underway at the Netherlands Cancer Institute. Scientists are exploring a novel combination of existing… -
news
Legislation & LitigationCourt Rejects Johnson & Johnson’s Bankruptcy Plan for Talc Lawsuits
A federal appeals court last week rejected an LTL Management bankruptcy filing, delivering a blow to the company’s plan to resolve thousands of… -
news
Research & Clinical TrialsMesothelioma Treatment Uses Natural Immune Cells
For patients with mesothelioma cancer, immunotherapy is a promising new field. Results from a recent study at Rice University in Houston are exciting. -
news
Research & Clinical TrialsStudy Shows Opdivo, Yervoy Effective After Mesothelioma Surgery
Patients with recurrent mesothelioma cancer often have few options. A new study by the Hyogo College of Medicine in Japan may have a… -
news
Research & Clinical TrialsBaylor Study: Mesothelioma ‘Staged Surgical Approach’ Increases Survival
Select patients diagnosed with mesothelioma cancer in both the thoracic and abdominal cavities still can achieve an extended survival if their treatment center… -
news
Legislation & LitigationUK Citizens Filing Asbestos Talc Claims In U.S. Courts
Residents of the United Kingdom have been among the growing number of personal injury plaintiffs filing lawsuits in U.S. courts, attributing their diagnoses of… -
news
Legislation & LitigationAvon Hit With $52.1M Verdict for Asbestos-Contaminated Talc
A California jury awarded $52.1 million to an Arizona woman diagnosed with mesothelioma cancer. The multimillion-dollar verdict combines damages against cosmetics giant Avon… -
news
Asbestos Exposure & BansDangers of Legacy Asbestos Detailed in UK Study
A recently published study from the United Kingdom has shown that legacy asbestos lingering in commercial and residential construction is more dangerous than expected. … -
news
Research & Clinical TrialsMesothelioma Surgery With Immunotherapy Proves Effective in Study
An immunotherapy combination given before aggressive surgery has shown impressive effectiveness in extending survival for pleural mesothelioma patients in a recent phase II… -
news
Research & Clinical TrialsStudy: Early Mesothelioma HIPEC Surgery Extends Survival
Sooner is better when it comes to aggressively treating peritoneal mesothelioma cancer with a combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Waiting could…